On this page
This entry or formulation may be investigational and may not correspond to an FDA-approved product; safety and efficacy may not have been established. Kairo lists it for identification and record-keeping only.
Overview
Product & regulatory status
Cosmetic wrinkle studies do not establish equivalence to injected botulinum toxin.
Design rationale
Argireline was designed using a region of SNAP-25, a protein involved in vesicle release. The proposed biochemical mechanism and a visible cosmetic effect are separate claims. [1]
What the evidence shows
Placebo-controlled wrinkle study
A trial in 60 Chinese participants compared a topical Argireline product with placebo over four weeks. Investigators reported improvements in peri-orbital wrinkle assessments, including skin-replica measurements. The small, short trial limits generalization. [1]
Finished formulation matters
A double-blind split-face study in 19 women compared hyaluronic-acid serum with and without Argireline. It found no significant difference in wrinkle scores between sides, illustrating that results are not consistently positive across formulations and assessments. [2]
What remains unknown
Long-term results, consistent benefit across products and skin types, and comparative effectiveness remain uncertain.
Safety
Keep route boundaries clear
These topical studies cannot establish safety or benefit from injecting Argireline. They also cannot exclude uncommon skin reactions or predict tolerance of every cosmetic ingredient combination. [1]
The serum vehicle changes the question
The split-face study tested Argireline as part of a hyaluronic-acid serum. Its results apply to that finished formulation and comparison, not to purified peptide powder or all products bearing the ingredient name. [2]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [3]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [4]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Is it Botox in a bottle?
That phrase overstates the evidence. The studies evaluated topical wrinkle appearance and do not demonstrate the same clinical action or magnitude of effect as botulinum toxin.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Argireline: randomized topical wrinkle trial2013 · Original research · PubMed
- Argireline in a hyaluronic acid serum2023 · Original research · PubMed
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.